Cambridge Cognition
@CANTABconnect
Followers
2K
Following
1K
Media
1K
Statuses
4K
We are a digital neuroscience company developing software products and services to better understand, detect and treat conditions affecting brain health.
Cambridge, England
Joined September 2014
Can changes in speech patterns be an early indicator of cognitive decline? https://t.co/De7Rd2eRXe
0
0
1
These developments represent a significant step forward in our collective mission to fight Alzheimer's disease and dementias. If these topics are relevant to your work, we would love to chat! Find out more here: https://t.co/VlRwIKV96p
0
0
1
At AAIC25, we will be presenting the poster "Sensitivity of Cognitive Outcome Measures to Plasma p-tau217 in Mild Cognitive Impairment in the AI-Mind study," by Alex Kaula. Sign up to be the first to download this research: https://t.co/s6lOAwHoxD
0
0
1
Check out our latest research at #AAIC25. This poster presents comprehensive data on the development of composite speech biomarkers, rigorously validated for use as a novel endpoint in MCI/AD clinical trials. Find out more: https://t.co/FvYNMRgTdV
0
0
0
Speech biomarkers for MCI/AD - presenting analytical and clinical validation in Dutch, Danish, German & Spanish! Discover the impact of our global validation research presented at AAIC 2025. Dive deeper: https://t.co/bGVHZaf99F
0
0
2
Ensuring Data Reliability in High-Frequency Remote Assessments: Sign up to be the first to receive our research and find out how we are building confidence in remote data collection: https://t.co/UGavx2VfTk
#AAIC2025 #DigitalBiomarkers #Alzheimers #Psychometrics #ClinicalTrials
1
0
1
We're thrilled to announce! We're presenting 4 exciting posters at #AAIC25! 🧠 Discover our latest science and get the insights shaping #CNS drug development: https://t.co/1qIsdXU0GP
#Alzheimers #DigitalBiomarkers #ClinicalTrials
0
0
2
We're looking forward to seeing you tomorrow at the Digital Biomarkers in Clinical Trials Summit! #digitalbiomarkers #digitalhealth #clinicaltrials #cognition #pharmaceuticalresearch
0
0
1
Join us at 11:20am on 25th June to hear real world examples of how digital assessments can improve patient engagement. Register now to secure your place: https://t.co/tCNRm8Hnqc
#DigitalBiomarkers #ClinicalTrials #DigitalHealth #PharmaInnovation
0
0
0
We're looking forward to this key event for leaders and innovators in #digitalhealth and #pharmaceuticalresearch, exploring evolving role of #digitalbiomarkers in #clinicaltrials to drive the acceleration of drug development. Secure your spot: https://t.co/FllOkmixj1
0
0
1
Sponsored by Biogen in collaboration with Apple, he study enrolled a representative sample of 23,004 participants across the United States and relied on Cambridge Cognition's CANTAB® platform for the core cognitive assessment. Read more here: https://t.co/U8cVMg7hr6
0
0
0
Michael Spilka shares his key takeaways from this year's #Schizophrenia International Research Society Congress, and the key findings on his poster presentations. Read more: https://t.co/fQARYtJOPg
0
0
0
ICYMI: Stay up-to-date on the future of dementia research and the key shifts that could redefine clinical trials and patient care in neurodegenerative diseases: https://t.co/uGhQDFDkag
#DementiaResearch #CNSDrugDevelopment #ClinicalTrials #Innovation #FutureofMedicine
0
0
0
The selection of the right cognitive assessment isn't just a methodological choice; it's a foundational element that underpins the reliability and impact of your clinical trial data. ➡️ Explore the factors to consider and the benefits of each approach: https://t.co/aTU9qcs1LS
0
0
0
AD/PD kicks off today with a packed agenda! 🥇Get our posters delivered to your inbox here: https://t.co/HJG0FnPltV
0
0
0
New Mild Cognitive Impairment insights! 💡 Nick Taptiklis's #ADPD2025 poster reveals novel reaction time measures from CANTAB® PAL. Discover how timing-based data enhances understanding of MCI. Download now! ➡️ https://t.co/ywPuNRiveA
#MCI #Neuroscience #Alzheimers #Parkinsons
0
1
1
The ability to conduct reliable cognitive testing remotely is crucial for expanding access and efficiency in studies related to aging and neurodegenerative diseases. Get the poster here! https://t.co/66kxkeDTL1
#Alzheimers #Parkinsons #ClinicalTrials #Neuroscience
0
0
0
Join our Chief Scientist for her poster "Novel Digital Measures of Reaction Time and Drawing Speed" from the @ideafastproject. Discover how our digital tools can provide unique insights into movement & accuracy in neurodegenerative disorders: https://t.co/ygPwyFPS5q
0
0
0
Does computerised cognitive testing have sufficient sensitivity for assessing cognitive impairment associated with #schizophrenia in clinical trials? Get the research: https://t.co/7d5jubgtJ4
#SIRS2025 #SchizophreniaResearch #ClinicalTrials #DigitalHealth
0
0
0
Can speech reveal the severity of #schizophrenia symptoms? Find out more: https://t.co/23KBmTzZ7r
0
0
0